Nova Patents
LU90591I2

Tumor necrosis factor-alpha and -beta receptors

Abstract

Tumor necrosis factor receptor proteins, DNAs and expression vectors encoding TNF receptors, and processes for producing TNF receptors as products of recombinant cell culture, are disclosed.

Term

Term ended

Projected expiry passed 31 May 2020, 6.3 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

94 members in 22 offices

This recordMember, by publication datePriority claim12 more offices are in the list below

Priority claims9

Priority claims
DocumentOfficeKindDate
40537089United States of AmericaA
40537089United States of AmericaA
42141789United States of AmericaA
42141789United States of AmericaA
52363590United States of AmericaA
52363590United States of AmericaA
US19890405370–––
US19890421417–––
US19900523635–––

Members94

Family members, oldest first
DocumentOfficeKind
CA2065346A1CanadaA1
IE903211A1IrelandA1
EP0418014A1European Patent Office (EPO)A1
CA2485553A1CanadaA1
WO9103553A1World Intellectual Property Organization (WIPO)A1
AU6178190AAustraliaA
JPH03133382AJapanA
IL95572D0IsraelD0
ZA907072BSouth AfricaB
NZ235148ANew ZealandA
DD297664A5German Democratic Republic (until 1990)A5
NO920862D0NorwayD0
NO920862LNorwayL
MX9203660AMexicoA
AU630497B2AustraliaB2
CA2133326A1CanadaA1
WO9319777A1World Intellectual Property Organization (WIPO)A1
AU3970293AAustraliaA
CA2123593A1CanadaA1
WO9406476A1World Intellectual Property Organization (WIPO)A1
AU4920993AAustraliaA
NO941780D0NorwayD0
NO941780LNorwayL
NO943617D0NorwayD0
EP0620739A1European Patent Office (EPO)A1
FI944516AFinlandA
NO943617LNorwayL
KR950700937ARepublic of KoreaA
US5395760AUnited States of AmericaA
IE63505B1IrelandB1
JPH07504203AJapanA
EP0670730A1European Patent Office (EPO)A1
JPH07508639AJapanA
EP0418014B1European Patent Office (EPO)B1
AT131871TAustriaT
ATE131871T1AustriaT1
DK0418014T3DenmarkT3
DE69024291D1GermanyD1
ES2080809T3SpainT3
GR3019333T3GreeceT3
AU670125B2AustraliaB2
NZ251820ANew ZealandA
NZ280051ANew ZealandA
AU671116B2AustraliaB2
DE69024291T2GermanyT2
EP0620739A4European Patent Office (EPO)A4
US5605690AUnited States of AmericaA
EP0670730A4European Patent Office (EPO)A4
NZ256293ANew ZealandA
US5712155AUnited States of AmericaA
JP2721745B2JapanB2
JPH10191986AJapanA
US5945397AUnited States of AmericaA
JP2960039B2JapanB2
KR100232688B1Republic of KoreaB1
CA2123593CCanadaC
FI20000833AFinlandA
FI105099BFinlandB
USRE36755EUnited States of AmericaE
LU90591I2This recordLuxembourgI2
NL300008I1Netherlands (Kingdom of the)I1
NL300008I2Netherlands (Kingdom of the)I2
US6201105B1United States of AmericaB1
US2002006391A1United States of AmericaA1
FI108645BFinlandB
NO312769B1NorwayB1
EP1239043A2European Patent Office (EPO)A2
EP1239043A3European Patent Office (EPO)A3
NO2002015I1NorwayI1
US6541610B1United States of AmericaB1
US2003082736A1United States of AmericaA1
US6572852B2United States of AmericaB2
EP0670730B1European Patent Office (EPO)B1
DE10075011I1GermanyI1
AT242322TAustriaT
ATE242322T1AustriaT1
DE69333027D1GermanyD1
US2003165459A1United States of AmericaA1
ES2197149T3SpainT3
DE69333027T2GermanyT2
DE10075011I2GermanyI2
CA2133326CCanadaC
CA2065346CCanadaC
FI20051161AFinlandA
US2006067934A1United States of AmericaA1
FI116943BFinlandB
US7057022B2United States of AmericaB2
US2006275868A1United States of AmericaA1
NO323197B1NorwayB1
IL95572AIsraelA
US7459528B2United States of AmericaB2
FI120042BFinlandB
US2009270592A1United States of AmericaA1
ES2080809T4SpainT4